Page last updated: 2024-10-25

cyproheptadine and Alzheimer Disease

cyproheptadine has been researched along with Alzheimer Disease in 2 studies

Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, S1
Fu, WY1
Fu, AKY1
Tong, EPS1
Ip, FCF1
Huang, X1
Ip, NY1
Zand, L1
Hoffman, SJ1
Nyman, MA1

Other Studies

2 other studies available for cyproheptadine and Alzheimer Disease

ArticleYear
Identification of new EphA4 inhibitors by virtual screening of FDA-approved drugs.
    Scientific reports, 2018, 05-09, Volume: 8, Issue:1

    Topics: Alzheimer Disease; Androstenes; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cyproheptadine; Di

2018
74-year-old woman with new-onset myoclonus.
    Mayo Clinic proceedings, 2010, Volume: 85, Issue:10

    Topics: Aged; Alzheimer Disease; Cyproheptadine; Diagnosis, Differential; Dopamine Antagonists; Dose-Respons

2010